Grant Bulletin

Below are links to funding opportunities through the National Institutes of Health (NIDDK) and the Cystic Fibrosis Foundation.

The Division of Diabetes, Endocrinology, and Metabolic Diseases (DDEM) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications through the exploratory/developmental (R21) grant mechanism from investigators with interests in selected areas of opportunity relevant to the mission of DDEM. One area in which such scientific opportunities exist is in the development of novel vectors and delivery systems for use in gene therapy of metabolic diseases, such as diabetes, and cystic fibrosis and other inborn errors of metabolism. Another component of interest may be tissue engineering relevant to diabetes, osteoporosis, cystic fibrosis, and other diseases within the mission of DDEM. Please refer to entire announcement:

Cystic Fibrosis Foundation
The Cystic Fibrosis Foundation announces competitive awards for research related to CF. Studies may be carried out at the subcellular, cellular, animal or patient levels. Support in the following categories may be requested by application. Office of Grants Management contact information: (800) FIGHT CF, or by email at